Ouabain and chloroquine trigger senolysis of BRAF‐V600E‐induced senescent cells by targeting autophagy-Reference-Cited by-同舟云学术

Ouabain and chloroquine trigger senolysis of BRAF‐V600E‐induced senescent cells by targeting autophagy

Published:2021-08-06 Issue:9 Volume:20 Page:
ISSN:1474-9718
Container-title:Aging Cell
language:en
Short-container-title:Aging Cell

Author:

L’Hôte Valentin¹^ORCID,Courbeyrette Régis¹,Pinna Guillaume¹,Cintrat Jean‐Christophe²,Le Pavec Gwenaëlle¹,Delaunay‐Moisan Agnès¹,Mann Carl¹^ORCID,Thuret Jean‐Yves¹^ORCID

Affiliation:

1. Université Paris‐Saclay CEA CNRS Institute for Integrative Biology of the Cell (I2BC) Gif‐sur‐Yvette Cedex France

2. Université Paris‐Saclay CEA INRAE Département Médicaments et Technologies pour la Santé (DMTS) SCBM Gif‐sur‐Yvette France

Funder

Fondation ARC pour la Recherche sur le Cancer

Publisher

Wiley

Subject

Cell Biology,Ageing

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/acel.13447

Reference45 articles.

1. The sodium pump and digitalis drugs: Dogmas and fallacies

2. Na/K-ATPase Y260 Phosphorylation–mediated Src Regulation in Control of Aerobic Glycolysis and Tumor Growth

3. Pro-apoptotic and cytostatic activity of naturally occurring cardenolides

4. Digoxin and ouabain increase the synthesis of cholesterol in human liver cells

5. Glucocorticoids delay RAF‐induced senescence promoted by EGR1;Carvalho C.;Journal of Cell Science,2019

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quercetin induces senolysis of doxorubicin-induced senescent fibroblasts by reducing autophagy, preventing their pro-tumour effect on osteosarcoma cells;Mechanisms of Ageing and Development;2024-08

2. In Vitro Investigation of Therapy-Induced Senescence and Senescence Escape in Breast Cancer Cells Using Novel Flow Cytometry-Based Methods;Cells;2024-05-15

3. Connecting epigenetics and inflammation in vascular senescence: state of the art, biomarkers and senotherapeutics;Frontiers in Genetics;2024-02-26

4. Current senolytics: Mode of action, efficacy and limitations, and their future;Mechanisms of Ageing and Development;2024-02

5. ATP1A1 is a promising new target for melanoma treatment and can be inhibited by its physiological ligand bufalin to restore targeted therapy efficacy;Cancer Cell International;2024-01-04